Prostate Cancer

Translational and Emerging Therapies
Herausgeber: Dawson, Nancy A; Kelly, W Kevin

• Broschiertes Buch

Produktbeschreibung

Scientists have reached a critical point in the development of new therapies for prostate cancer. The information gleaned from the Human Genome Project, alongside the emergence of new technologies for the use of genetic data has expanded the physician's understanding of disease progression and widened his armamentarium for prostate cancer prevention and control. This expertly-written reference thoroughly analyzes the scientific principles and methodologies behind the most recent translational therapies and provides the necessary context, data, and studies for practitioners to select appropriate candidates for treatment and effectively apply new therapies in clinical practice.

---

Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.

Produktdetails

• Verlag: Taylor & Francis Ltd (Sales)
• Seitenzahl: 352
• Erscheinungstermin: 5. September 2019
• Englisch
• Abmessung: 226mm x 152mm x 20mm
• Gewicht: 658g
• ISBN-13: 9780367390181
• ISBN-10: 0367390183
• Artikelnr.: 57732231

Autorenporträt

Nancy A. Dawson, W. Kevin Kelly

Inhaltsangabe

The Molecular Pathogenesis and Pathophysiology of Prostate Cancer. Targeted
Therapies for Cancer: Definitions and Attributes. Novel Biomarkers for
Disease Diagnosis, Prognosis, and Prediction. The Endothelin Pathway and
Its Modulation in Prostate Cancer. Targeting Extracellular Molecules in
Prostate Cancer-Mechanisms to Inhibit Entry into the Cell-Signaling Abyss.
Immunologic Approaches to Prostate Cancer. Gene Therapy and Novel Clinical
Trial Design. Angiogenesis Inhibitors in Prostate Cancer. What Antisense
Oligonucleotides Have Promise in Prostate Cancer. Novel Approaches to
Androgen Receptor Blockade. Can Post-Transcription Modifiers Change the
Course of Prostate Cancer?. Telomere Targeting Agents. Expanding the Role
of EGFR Inhibitors in Prostate Cancer. Bone-Directed Therapy in Prostate
Cancer: Rationale and Novel Approaches. Inhibiting the Proteasome in
Advanced Prostate Cancer. Hsp90: A Target for Prostate Cancer Therapy.
Vitamin D Analogs and Their Role in Prostate Cancer. Other Novel Therapies.
Molecular Imaging, Clinical Trial Design, and the Development of Emerging
Therapies for Metastatic Prostate Cancer